When using the TCGA-GBM dataset, we observed that MTAP loss of expression was more pronounced within the classical subtype (65.2%), corroborating previous reports that patients with classical subtype are characterized by CDKN2A gene deletion that is contiguous with the MTAP gene [26]. Here, MTAP is linked to glioblastoma.